双丹明目胶囊对DR患者眼底和视力的改善
常贯超 （ 邢台医学高等专科学校 ）
董 晓 （ 邢台医学高等专科学校 ）
孙丽娜 （ 邢台医学高等专科学校 ）
王英敏 （ 邢台医学高等专科学校 ）
高利娟 （ 邢台医学高等专科学校第二附属医院 ）
https://doi.org/10.37155/2661-4766-0506-39Abstract
双丹明目胶囊应用于糖尿病视网膜病变患者治疗，可有效改善眼底和视力临床疗效，降低中医症候积 分，消除炎症反应，纠正眼动脉血流动力学，降低VEGF/KDR信号通路，安全有效，值得临床进一步研究并推广。
Keywords
双丹明目胶囊；糖尿病视网膜病变；临床疗效；血管内皮生长因子；激酶插入域受体Full Text
PDFReferences
[1] Teo ZL, Tham YC, Yu M, et al. Global prevalence of
diabetic retinopathy and projection of burden through 2045:
systematic review and meta-analysis. [J]. Ophthalmology.,
2021, 128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027.
[2] Fung TH, Patel B, Wilmot EG, et al. Diabetic
retinopathy for the non-ophthalmologist. [J]. Clin
Med (Lond)., 2022, 22(2):112-116. doi: 10.7861/clinmed.2021-0792.
[3] Saini DC, Kochar A, Poonia R. Clinical correlation
of diabetic retinopathy with nephropathy and neuropathy. [J].
Indian J Ophthalmol., 2021, 69(11):3364-3368. doi: 10.4103/
ijo.IJO_1237_21.
[4] Le NT, Kroeger ZA, Lin WV, et al. Novel treatments
for diabetic macular edema and proliferative diabetic
retinopathy. [J]. Curr Diab Rep., 2021, 21(10):43. doi:
10.1007/s11892-021-01412-5.
[5]赵永旺,符超君,颜家朝,等.双丹明目胶囊对糖尿
病视网膜病变大鼠血液流变学和视网膜微血管的影响
[J].眼科新进展,2022,42(5):342-346. doi: 10.13389/j.cnki.
rao.2022.0069.
[6]Zhu AX, Abbas AR, de Galarreta MR, et al. Molecular
correlates of clinical response and resistance to atezolizumab
in combination with bevacizumab in advanced hepatocellular
carcinoma. [J]. Nat Med., 2022, 28(8):1599-1611. doi:
10.1038/s41591-022-01868-2.
[7]Saoud H, Aflouk Y, Ben Afia A, et al. Association of
VEGF-A and KDR polymorphisms with the development of
schizophrenia. [J]. Hum Immunol., 2022, 83(6):528-537. doi:
10.1016/j.humimm.2022.04.003.
diabetic retinopathy and projection of burden through 2045:
systematic review and meta-analysis. [J]. Ophthalmology.,
2021, 128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027.
[2] Fung TH, Patel B, Wilmot EG, et al. Diabetic
retinopathy for the non-ophthalmologist. [J]. Clin
Med (Lond)., 2022, 22(2):112-116. doi: 10.7861/clinmed.2021-0792.
[3] Saini DC, Kochar A, Poonia R. Clinical correlation
of diabetic retinopathy with nephropathy and neuropathy. [J].
Indian J Ophthalmol., 2021, 69(11):3364-3368. doi: 10.4103/
ijo.IJO_1237_21.
[4] Le NT, Kroeger ZA, Lin WV, et al. Novel treatments
for diabetic macular edema and proliferative diabetic
retinopathy. [J]. Curr Diab Rep., 2021, 21(10):43. doi:
10.1007/s11892-021-01412-5.
[5]赵永旺,符超君,颜家朝,等.双丹明目胶囊对糖尿
病视网膜病变大鼠血液流变学和视网膜微血管的影响
[J].眼科新进展,2022,42(5):342-346. doi: 10.13389/j.cnki.
rao.2022.0069.
[6]Zhu AX, Abbas AR, de Galarreta MR, et al. Molecular
correlates of clinical response and resistance to atezolizumab
in combination with bevacizumab in advanced hepatocellular
carcinoma. [J]. Nat Med., 2022, 28(8):1599-1611. doi:
10.1038/s41591-022-01868-2.
[7]Saoud H, Aflouk Y, Ben Afia A, et al. Association of
VEGF-A and KDR polymorphisms with the development of
schizophrenia. [J]. Hum Immunol., 2022, 83(6):528-537. doi:
10.1016/j.humimm.2022.04.003.
Copyright © 2024 常贯超,董 晓,孙丽娜,王英敏,高利娟
Publishing time:2023-12-31
This work is licensed under a Creative Commons Attribution 4.0 International License
Email
Location